New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
10:00 EDTARRYArray BioPharma now sees FY13 EPS (55c), prior view (60c)
Consensus for FY13 EPS (58c). Lowered FY13 revenue view to $60M from $62M prior guidance, consensus $63.03M. Guidance from slides for Q2 earnings conference call.
News For ARRY From The Last 14 Days
Check below for free stories on ARRY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ARRY

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use